TrialClinical drug investigation2015

Dose-exposure proportionality of a novel recombinant follicle-stimulating hormone (rFSH), FE 999049, derived from a human cell line, with comparison between Caucasian and Japanese women after subcutaneous administration.

Håkan Olsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.